Dr
Clara
Orofino Peña

Senior European Patent Attorney

Glasgow Office

Chemistry

Telephone. +44(0) 141 229 5800
Email. [email protected]

Experience

Clara has extensive experience drafting and prosecuting patent applications in the fields of pharmaceuticals, process Chemistry, materials Chemistry, textiles, batteries and fuel cells, surfactants, medical devices, and other mechanical devices.

She manages global IP portfolios in a variety of technologies for universities, SMEs and multinationals, and her main body of work is European and UK patent drafting and prosecution for multinationals and foreign associates. Clara also has experience in patentability and freedom to operate opinions, European patent oppositions and appeals.

Clara speaks multiple languages and enjoys providing focused technical and commercial advice to her clients.

Qualifications

Patent Attorney

European


BSC

Pure and Applied Chemistry - University of Strathclyde

PHD

PhD in Materials Chemistry - University of Strathclyde

POSTGRADUATE DIPLOMA OR CERTIFICATE

IPRegs Intellectual Property Litigation Certificate (UK)

OTHER

Licenciatura en Quimica (Equivalent to MSci in Pure and Applied Chemistry) - University of the Basque Country

Publications

Managing IP's Rising Stars 2021

View publication online

CSR

Clara mentors trainees on daily drafting and prosecution matters and has delivered tutorials for the EQEs.

Related News

Artificial intelligence inventions in healthcare – can you patent them in Europe?

Artificial Intelligence (AI) has moved from the realm of science fiction firmly into the mainstream of technological innovation. Trained AI models in some cases are able to perform data analysis …

Read article

Patenting digital mental health

Mental health and behavioural disorders have a profound impact on wellbeing worldwide, with an estimated 13% of the global population suffering from a mental health or substance use disorder [1]. …

Read article

Patenting antibodies in the US and Europe

Is the USPTO now stricter than the EPO on antibody claims? A consideration of recent developments from both sides of the pond. Patent protection for monoclonal antibodies, bispecific antibodies and …

Read article

Patentability of Simulations in Europe

Simulations offer a powerful tool in modern-day engineering. Subjecting designs to initial testing in a simulated environment will, for many designs, reduce costs owing to reduced needs to produce and …

Read article

Blockbuster blood thinning patent revoked

Summary Mr Justice Meade has revoked Bristol Myers Squibb’s (BMS) European patent No. EP1427415 (EP’415) and corresponding supplementary protection certificate (SPC) that relate to the compound Apixaban (ELIQUIS) for lack …

Read article
Event - 10th May 2022

The HGF IP in Healthcare Conference 2022

After a challenging couple of years, we are delighted to invite you to join us for HGF’s eighth annual IP in Healthcare Conference. We will review the latest intellectual property …

Event details
Event - 10th May 2022

HGF UPC events in Germany and Austria 2022

HGF is holding a webinar and an in-person event covering the UPC in Germany and Austria this Spring. The provisional phase of the Unified Patent Court (UPC) is now underway …

Event details
Event - 19th May 2022

HGF Complete webinar: comparison of registered and unregistered design rights procedures before the EUIPO and UKIPO

HGF is hosting a series of HGF Complete webinars this Spring. Our expert speakers will discuss trade marks and designs in the EU and the UK. We will compare and …

Event details

Let's talk

If you would like to discuss how HGF could help you, contact one of our IP specialists.